Therapeutic efficacy of the metered dose inhaler formulation of budesonide/formoterol in Hungarian children with asthma

被引：0
|
作者：
Endre, L. [1 ]
DuBuske, L. [2 ]
机构：
[1] Heim Pal Childrens Hosp, Budapest, Hungary
[2] Immunol Res Inst New England, Gardner, MA USA
来源：
ALLERGY | 2011年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1552
引用
收藏
页码：586 / 586
页数：1
相关论文
共 50 条
  • [31] Long-term efficacy and resource utilization after treatment with budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) compared with budesonide dry powder inhaler (DPI) alone in children with asthma
    Berger, W. E.
    Leflein, J. G.
    Uryniak, T.
    O'Brien, C. D.
    O'Dowd, L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S8 - S8
  • [32] Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler
    Bodzenta-Lukaszyk, Anna
    Pulka, Grazyna
    Dymek, Andrzej
    Bumbacea, Dragos
    McIver, Tammy
    Schwab, Birgit
    Mansikka, Heikki
    RESPIRATORY MEDICINE, 2011, 105 (05) : 674 - 682
  • [33] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
    Chen Wang
    Ting Yang
    Jian Kang
    Rongchang Chen
    Li Zhao
    Huijie He
    Pryseley N. Assam
    Rong Su
    Eric Bourne
    Shaila Ballal
    Kiernan DeAngelis
    Paul Dorinsky
    Advances in Therapy, 2020, 37 : 1591 - 1607
  • [34] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
    Wang, Chen
    Yang, Ting
    Kang, Jian
    Chen, Rongchang
    Zhao, Li
    He, Huijie
    Assam, Pryseley N.
    Su, Rong
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Dorinsky, Paul
    ADVANCES IN THERAPY, 2020, 37 (04) : 1591 - 1607
  • [35] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) Versus Budesonide Dry Powder Inhaler (DPI) on Predose FEF25-75% over 26 Weeks in Children with Asthma
    Berger, W. E.
    Geller, D. E.
    O'Brien, C. D.
    Uryniak, T.
    Lampl, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler
    Ganderton, D
    Lewis, D
    Davies, R
    Meakin, B
    Church, T
    RESPIRATORY MEDICINE, 2003, 97 : S4 - S9
  • [37] In Vitro Drug Delivery Performance of a New Budesonide/Formoterol Pressurized Metered-Dose Inhaler
    Chambers, Frank
    Ludzik, Andrew
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2009, 22 (02) : 113 - 120
  • [38] Twelve-week, randomized, placebo-controlled, Multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma
    Corren, Jonathan
    Korenblat, Phillip E.
    Miller, Christopher J.
    O'Brien, Christopher D.
    Mezzanotte, William S.
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 823 - 843
  • [39] Long-term safety and systemic effects of budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) in children with asthma
    Leflein, J. G.
    Berger, W. E.
    Uryniak, T.
    Vervaet, P.
    O'Dowd, L.
    O'Brien, C. D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S155 - S155
  • [40] Erratum to: The effect of budesonide/formoterol pressurized metered-dose inhaler on predefined criteria for worsening asthma in four different patient populations with asthma
    Kevin R. Murphy
    Tom Uryniak
    Ubaldo J. Martin
    James Zangrilli
    Drugs in R&D, 2012, 12 (1) : 15 - 15
12345